Recently, data from the BACTRAC program demonstrated that the intracranial vascular cell adhesion molecule-1 (VCAM1) was positively related to infarct volume, edema volume, and stroke severity in patients receiving MT treatment (16). This evidence concerns the gene VCAM1 and Stroke.